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1. Introduction  
Sporotrichosis is a subcutaneous mycosis that is globally distributed. Areas of high 
endemicity are Latin America, South Africa, India and Japan (Lopez-Romero et al., 2011; 
Queiroz-Telles et al., 2011). This infection is caused by the dimorphic fungus, previously 
described as the single species Sporothrix schenckii (Coura, 2005), that is now named the S. 
schenckii species complex (Marimon et al., 2006, 2007, 2008), which is associated with plants 
and soil (Ramos e Silva et al., 2007). In humans, sporotrichosis has been regarded as a job-
related disease that usually occurs in the form of isolated cases or small outbreaks and 
affects only people exposed to plants or soil rich in organic matter and occasionally 
laboratory technicians (Copper et al., 1992; Hajjeh et al., 1997). 
The fungus S. schenckii was isolated for the first time in 1896 by Benjamin Schenck from a  
36-year-old male patient who presented with lesions on his right hand and arm. This isolate 
was classified into the genus Sporotrichum (Schenck, 1898). Hekton and Perkins described 
the second sporotrichosis case in 1900. These investigators isolated the fungus and created 
the current denomination, Sporothrix schenckii (Hekton & Perkins, 1900, as cited in Coura, 
2005).  
In the early 1900s, sporotrichosis was a common disease in France, and many features of the 
fungus and the less-common clinical manifestations were described. At the same time, 
potassium iodide began to be used to treat sporotrichosis (Kwon-Chung & Bennett, 1992) 
and is a satisfactory therapy for treatment of sporotrichosis, until now. 
The first reported case of natural animal infection was described in 1907 by Lutz and 
Splendore in rats from Brazil (Lutz & Splendore, 1907, as cited in Coura, 2005). In 1908, in 
Brazil, Splendore described the asteroid bodies around Sporothrix yeast cells, which are 
used to diagnose sporotrichosis during histological examinations (Kwon-Chung & 
Bennett, 1992). 
Classically, subcutaneous mycosis is usually associated with puncture injuries in farmers, 
florists, leisure gardeners, landscapers and greenhouse workers. However, in the zoonotic 
sporotrichosis endemic area of Rio de Janeiro, Brazil, transmission of the disease has been 
occurring broadly in the populace through the scratches or bites of S. schenckii infected cats 
(Schubach et al., 2008). Less commonly, other form of acquisition of the infection is 
inhalation of fungus conidia from soil (Rohatgi, 1980) and from infected animals, being cats 
the most involved. Sporotrichosis is primarily a cutaneous disease. After inoculation, a 
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papule develops at the site of inoculation and generally ulcerates, forms into nodules and 
then develops proximal to the primary lesion followed by lymphatic distribution and often 
ulceration. This is the lymphocutaneous form and is followed in frequency by the fixed 
form, which is characterised by a localised lesion without lymphatic involvement (Schubach 
et al., 2008). Disseminated forms are unusual and frequently occur in immunosuppressed 
hosts (Schechtman, 2010). Disseminated cutaneous sporotrichosis is primarily characterised 
by multiple lesions scattered over several parts of the body or the spread of haematogenous 
lesions. Osteoarticular (Campos-Macías et al., 2006) and pulmonary lesions (Losman & 
Cavanaugh, 2004; Callens et al., 2005) are the most common extracutaneous forms. All forms 
are rare in normal hosts. Mucosal involvement is sporadic, and the conjunctiva is the most 
commonly affected mucosa (Schubach, et al., 2005). Meningitis is one of the worst 
complications of S. schenckii infection, and several recently reported cases describe AIDS as 
an underlying risk factor (Galhardo et al., 2010). 
Pathogenic fungi of the genus Sporothrix are dimorphic in the environment or when cultured 
in the laboratory at 25-30ºC. In the filamentous form, they present as hyaline, septate, 
branched hyphae with single-celled conidia of two types: hyaline and brown 
(dematiaceous). Hyaline conidia are small, ovoid and usually occur in the apical portion of 
conidiophores. Dematiaceous conidia are large and ovoid with a thick cell wall and are 
present along the entire length of the hyphae (Siegler et al., 1990). Macroscopically, 
filamentous S. schenckii colonies are initially white and gradually become brown to dark 
black as the fungus produces the conidia, which are unable to form chains. In contrast, the 
parasitic phase and the yeast phase of S. schenckii that develops when the fungus is cultured 
in appropriate culture media at 35º-37ºC, resembles cigar-shaped oval yeast cells, which 
may have one or more buds (Ramos e Silva et al., 2007). Macroscopically, colonies of S. 
schenckii grown at 37ºC have a yellowish-beige colour and a creamy texture. 
Sporothrix schenckii belongs to the Fungi Kingdom. After the substantial fungal taxonomy 
revision by Guarro and co-workers, this fungus was placed in the Ascomycota Division, 
Pyrenomycetes Class, Ophiostomatales Order, Ophiostomataceae Family (Guarro et al., 1999). 
Recently, it was suggested that S. schenckii should not be considered the only taxon, which 
causes sporotrichosis in human and animals because four new species have been identified 
(Marimon et al., 2006, 2007, 2008). 
Mycoses can be challenging to diagnose, and accurate interpretation of laboratory data is 
important to ensure appropriate treatment. Although the clinical manifestations of 
sporotrichosis are well described, the diagnosis of this mycosis cannot be based on clinical 
information alone because the symptoms of sporotrichosis overlap of with those of other 
diseases. Also, a definitive diagnosis requires isolation of Sporothrix spp. on specific culture 
media or visualisation of the yeast form during direct examination of clinical specimens 
using specific fungal staining techniques. However, these procedures are time consuming, 
usually taking a minimum of 15 days, and lack sensitivity. Furthermore, Sporothrix spp. 
structures can be confused with those of other fungal pathogens when visualised 
microscopically. Given these difficulties, other techniques have been developed to 
supplement culture and microscopic examination. These laboratory tests have a rapid 
turnaround time and reasonable specificity and sensitivity. 
In this chapter, some of the well-established clinical and laboratorial diagnoses will be 
discussed and current conventional diagnostic tools will be reviewed. Additionally, we will 
outline of the development of novel diagnostic methods and discuss their relative merits 
and disadvantages.  
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2. Diagnosis  
Sporotrichosis is classically diagnosed by correlation of clinical, epidemiological and 
laboratorial data. Erythematous, ulcerated, or verrucous lesions that appear at the site of a 
skin injury that are caused by trauma with material from vegetal origin or by a scratch or 
bite from an animal, such as a cat, with subsequent nodular lymphangitic spread, are strong 
clinical and epidemiological indicators of mycotic infection (Coura, 2005). To confirm the 
diagnosis, laboratorial examinations must be performed. Typical laboratory analyses 
involved in sporotrichosis diagnosis include microscopic examination and culture of clinical 
specimens, such as skin biopsies or pus, from the patient’s lesions. Although, in cases of 
disseminated or extracutaneous sporotrichosis other specimens such as sputum, urine, 
blood, synovial and cerebrospinal fluids can be analysed depending on the affected organs 
or systems (Kwon-Chung & Bennet, 1992). 
Currently, there are additional diagnostic tools available for the diagnosis of sporotrichosis. 
For instance, serological techniques involving antibody detection against S. schenckii 
antigens have been developed using different enzyme linked immunosorbent assays 
(ELISA) formats and antigenic preparations (Almeida-Paes et al., 2007a; Bernardes-
Engemman et al., 2005). Molecular methods to detect S. schenckii DNA in clinical specimens, 
including tissue fragments, are also being studied in several laboratories to facilitate quick 
diagnosis of infection (Hu et al., 2003; Kano et al., 2003). The next sections will focus on these 
diagnostic applications for diagnosis sporotrichosis. 
2.1 Clinical types and differential diagnosis  
2.1.1 Clinical types 
Sporotrichosis affects both sexes and can occur at any age. In most cases, sporotrichosis is a 
benign infection that is restricted to the skin, subcutaneous tissue and adjacent lymph 
vessels (Kwon-Chung & Bennett, 1992; Rippon, 1988). 
The disease can be divided into four clinical forms (Sampaio et al., 1954, as cited in Ramos-e-
Silva et al., 2007): 
The lymphocutaneous form is the most common presentation and accounts for up to 75% of 
cases and is the easiest sporotrichosis to diagnose. The lesions are usually located on the 
upper extremities and are characterised by the appearance of a primary lesion at the site of 
inoculation after two or three weeks. This lesion can be ulcerated with an infiltrated base or 
a papular, nodular, nodular-ulcerative, ulcerative-gummy or vegetative plaque. From the 
initial injury, it forms a chain of painless nodules along the path of the lymph vessels, which 
may soften and ulcerate with little exudates that can be classified as sporotrichoid (Figure 1). 
Usually, the regional lymph nodes are not involved, and no skin changes are observed 
between the nodes. Erythema can be present, but the pain is usually mild. A secondary 
infection may occur and is associated with increased erythema and suppuration. 
The fixed cutaneous form is the second most common and accounts for approximately 20% 
of cases. The lesion remains confined to the inoculation site and the lymph vessels are not 
involved. The lesions are ulcers (Figure 2), verrucous, or infiltrated plaques. Small satellite 
lesions are common and are frequently observed in children. The upper and low extremities 
are the most common sites of lesions, and children present with a high index of lesions on 
the face. Unlike the lymphocutaneous form, patients with the fixed cutaneous form do not 
present systemic symptoms. However, if left untreated, the lesions may evolve into a 
chronic course, and a spontaneous involution of the lesion can occur. 
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Fig. 1. Lymphocutaneous sporotrichosis.  
 
 
Fig. 2. Fixed cutaneous sporotrichosis. 
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The disseminated cutaneous form presents with nodular, gummy, or ulcerated 
disseminated lesions (Figure 3). Following inoculation of the skin, there is a haematogenous 
dissemination, which initially presents as softened subcutaneous lesions that can ulcerate 
after weeks or months. Although quite rare, it has been reported in AIDS patients and in 
patients submitted to a long course of steroid therapy as the first manifestation of this 
syndrome. Disseminated cutaneous sporotrichosis is more frequently observed (up to 16% 
of cases) during endemic zoonotic sporotrichosis in non-immunosuppressed patients 
infected by cat zoonotic transmission of the fungus (Barros et al., 2004; Freitas et al., 2010), 
which is attributed to multiple inoculations.  
 
 
Fig. 3. Disseminated cutaneous sporotrichosis. 
The extracutaneous form appears in less than 5% of cases and is difficult to diagnose. It 
arises after haematogenous spread of the fungus, conidial inhalation, contact with a skin 
lesion or direct inoculation of a mucosal site. Any organ or tissue can be affected by 
sporotrichosis, and the symptoms are specific to the organ involved and are then followed 
by fever and general commitment in some cases. Involvement can be unifocal or multifocal. 
Immunosuppression, caused by conditions such as diabetes, alcoholism, malignancy, 
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steroid therapy, chronic obstructive pulmonary disease (COPD) and AIDS, is common in the 
pulmonary and nervous forms (Kwon-Chung & Bennett, 1992; Rippon, 1988). Some points 
of emphasis are: 
 Bones and joints are the most commonly affected sites after the skin. The most 
commonly affected bones are the tibia, small bones of hands, radius, ulna, skull and 
face. Additionally, the joints of the hands, elbow, wrist, knee and ankle are also 
commonly affected. Most patients have infection of a single joint, which presents as a 
solitary granuloma. Destructive arthritis (Figure 4) or tenosynovitis may occur. 
 
 
Fig. 4. Bilateral destructive lesions on the knees and on the left wrist in a patient with 
osteoarticular sporotrichosis. 
 Pulmonary infection is frequently caused by inhalation of conidia and is not caused by 
dissemination of the fungus. Clinically, pulmonary sporotrichosis manifests as a 
chronic pulmonary disease with cavitation or hilar massive lymphadenopathy, the later 
has a certain frequency of spontaneous resolution. 
 Ocular infection can result from an exogenous infection or haematogenous 
dissemination. It may manifest as conjunctivitis with characteristic visible granulomas, 
episcleritis, dacryocystitis, corneal ulceration, uveitis, nodular iritis, retrobulbar lesion, 
panophthalmitis, ulceration or ectropia and can lead to total blindness in rare cases. 
Cases of isolated granulomatous conjunctivitis have been reported in Brazil without 
cutaneous disease and are related to cat zoonotic transmission (Barros et al., 2004). 
 The mucosa in the mouth, pharynx, larynx and nose can be infected by both direct and 
haematogenous routes. Exanthema, ulceration, suppuration and vegetation are clinical 
manifestations. 
 Infection of the nervous system presents as brain abscesses or chronic meningitis, which 
is indolent and is associated with hypoglycorrhachia, hyperproteinorrhachia and low 
mononuclear cell counts. A common and potentially serious complication in these cases 
is hydrocephalus. 
The first-choice for treatment of the cutaneous forms is oral itraconazole. Oral terbinafine is 
an alternative medication. Potassium iodide, despite being a classical and inexpensive drug, 
is difficult to tolerate and does not have sufficient scientific background to be recommended 
for sporotrichosis. Treatment with venous amphotericin B is reserved for severe patients 
and is also an option for the disseminated forms involving internal organs. 
Immunosuppressed patients often need higher doses of itraconazole and longer courses of 
treatment (Kauffman et al., 2007).  
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2.1.2 Differential diagnosis 
Lymphocutaneous sporotrichosis is fairly common and can be confidently diagnosed. 
However pyoderma, atypical Mycobacterium and Nocardia infection as well as leishmaniasis 
must also be considered (Coura, 2005). 
The clinical symptoms of the fixed form can be similar to pyoderma, paracoccidioidomycosis, 
chromoblastomycosis, cutaneous tuberculosis, atypical mycobacteria, tertiary syphilis, 
leishmaniasis, and even skin cancer.  
Lesions of the disseminated cutaneous form can be confused with other deep mycosis, such 
as paracoccidioidomycosis or histoplasmosis, or with atypical mycobacteria and non-
infectious granulomatous diseases. 
The disseminated extracutaneous forms are diagnosed differently according to the affected 
organ. Other fungal conjunctivitis, bacterial osteomyelitis, pulmonary fungal infections, 
tuberculosis and sarcoidosis should also be considered. 
2.2 Conventional diagnosis  
Depending on which clinical specimen is sent to the mycology laboratory for diagnosis, 
some procedures must be performed before microscopic and culture analyses. Skin biopsies 
should be sent to the laboratory in a sterile physiological saline solution. Water and 
formaldehyde are not suitable as transporter because they interfere with the microbiological 
tests. In the laboratory, skin/mucosa fragments have to be triturated using surgical scissors 
(Figure 5). Grinding the clinical specimen with a mortar and pestle should be avoided 
because it can destroy fungal structures present on the material. Pus from ulcerated lesions 
does not require special treatment and can be analysed directly after sample collection 
(Molinaro et al., 2010). 
 
 
Fig. 5. Skin fragment being triturated for mycological examination. 
Direct microscopic examination of the specimens is typically performed on specimens in 
10% potassium hydroxide or 4% sodium hydroxide to detect parasitic cigar shaped-budding 
yeast-like cells using a light microscope with a magnification of 400X to 1000X. These fungal 
cells are small (2-6µm in diameter), rare and hard to detect during direct examination of the 
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specimens obtained from human patients (Kwon-Chung & Bennett, 1992) or from domestic 
animals, such as dogs (Schubach et al., 2006). On the other hand, when this test is performed 
on skin biopsies collected from cats infected with S. schenckii yeast cells are easily observable 
(Figure 6A) because cats have a high fungal burden on their lesions (Schubach et al., 2004).  
Although yeast-like cells can be observed during microscopic examination in a few cases, 
they do not provide a definitive diagnosis of sporotrichosis. Histoplasma capsulatum var. 
capsulatum and Candida glabrata, two other pathogenic fungi that may cause skin infections, 
can also appear as small, round or oval yeast cells similar to S. schenckii (Larone, 2002). 
To identify the fungus, fluorescent methods using calcofluor white dye or fluorescent-
antibody staining can be performed. However, these techniques are expensive and are not 
available in most laboratories, especially in underdeveloped countries. Staining methods, 
including the Gram and Giemsa preparations, also aid in the microscopic identification of 
clinical specimens from patients with sporotrichosis. When the Gram stain is performed on 
the clinical specimens, the yeast cells are positively stained and occasionally surrounded by 
giant or polymorphonuclear cells (Figure 6B). Although both fluorescent and staining 
methodologies facilitate the identification of fungal cells when compared to the clarification 
by hydroxide solutions, both procedures lack sensitivity (Lacaz et al., 2002).  
 
 
Fig. 6. Direct examination of clinical specimens from patients with sporotrichosis. (A) Skin 
biopsy of a cat with sporotrichosis showing several yeast-like budding cells. Magnification 
400X. (B) Gram stain of pus from a human patient with sporotrichosis showing cigar shaped 
yeast-like cells. Magnification 1000X. 
Histopathological examination using a tissue fragment in formaldehyde is important for the 
diagnosis of sporotrichosis. Although S. schenckii yeast-like cells may be seen in skin 
biopsies with the routinely used hematoxylin and eosin (H&E) stains, other stains such as 
Gomori methenamine silver (GMS) or periodic acid-Schiff (PAS) can be used to confirm 
identification of fungal elements (Figure 7A). Parasitic cells of S. schenckii, which can be 
found within phagocitic cells or in the extracellular space, are difficult to see due to the 
paucity of these cells in lesions from human patients (Larone, 2002; Quintella et al., 2011).  
The reaction of the tissue is another important characteristic that should be evaluated during 
histopathologic examination of skin biopsies during diagnosis of sporotrichosis. S. schenckii 
usually causes a mixed suppurative and granulomatous inflammatory response in the dermis 
and adjacent subcutaneous tissue (Figure 7B). Cases of disseminated disease also present a 
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mixed inflammatory reaction. Fibrosis and micro abscess are frequently observed on 
cutaneous infections. Moreover, hyperkeratosis, parakeratosis and pseudoepitheliomatous 
hyperplasia may also occur (Larone, 2002). In addition to intact polymorphonuclear cells, the 
granuloma formed during sporotrichosis may also contain cellular debris, caseous material, 
lymphocytes, plasmocytes, giant and epithelioid cells, fibroblasts and yeasts (Quintella et al., 
2011). Some authors also report that foreign material of vegetal origin related to the traumatic 
inoculation of the agent may be found in rare cases (Orellana et al., 2009). 
 
 
Fig. 7. Histological examination of skin biopsies from patients with sporotrichosis. 
(A) Gomori methenamine silver stain presenting a yeast-like cell with a cigar-shaped bud, 
suggestive of S. schenckii. Magnification 400X. (B) Hematoxylin and eosin stain presenting a 
suppurative and granulomatous reaction with neutrophils. Magnification 400X. (Courtesy of 
Leonardo P. Quintella.) 
Some histopathologic changes on analysed tissues may be also related to the observation of 
the etiologic agent on tissue sections. The presence or predominance of epithelioid 
granulomas, caseous/fibrinoid necrosis and fibrosis as well as the occurrence of foreign 
body granulomas with predominance of lymphocytes is related to a lack of fungal 
observation. Suppurative granulomas, neutrophils and liquefaction are more common when 
S. schenckii yeast-like cells are encountered (Quintella et al., 2011). 
Several authors observed the Splendore-Hoeppli reaction on histopathologic tissue sections 
from sporotrichosis patients. This reaction indicates a localised immunologic response to 
antigens of several infectious organisms, such as fungi, bacteria and parasites (Hussein, 
2008), and appears as a radiating homogenous, refractile, eosinophilic, club-like material 
surrounding a central eosinophilic focus (Larone, 2002). Splendore first observed this 
structure in 1908 on tissue sections from patients with sporotrichosis and afterwards by 
Hoeppli in 1932 around schistosome larvae (Kwon-Chung & Bennett, 1992). Positive 
identification of this structure in tissue sections from patients with sporotrichosis ranges 
from 20% to 66% (Gezuele & Rosa, 2005); although other authors reported that this structure 
was not observed in several analysed samples (Quintella et al., 2011).  
These histopathologic findings help to differentiate sporotrichosis from other diseases. For 
instance, during histoplasmosis infection, the neutrophilic inflammatory response is a mixed 
of suppurative and granulomatous reactions, and in sporotrichosis are not observed. 
Suppurative tissue reactions are observed in candidiasis, especially when it is caused by  
C. glabrata, where the absence of hyphae and pseudohyphae elements can mimic 
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sporotrichosis; however, granulomas are not usually formed (Larone, 2002). On dogs with 
sporotrichosis, lesions present well-formed granulomas with marked neutrophil infiltration. 
Frequently, lymphocytes and macrophages are absent on peripheral infiltrate, which 
facilitates the differentiation between sporotrichosis and leishmaniasis (Miranda et al., 2010). 
Definitive diagnosis of sporotrichosis is based on the isolation and identification of its 
etiological agent in culture (Kwon-Chung & Bennett, 1992). Isolation of S. schenckii can be 
easily attained after spreading the clinical specimens on Sabouraud Dextrose Agar 
supplemented with 400mg/L chloramphenicol to avoid bacterial contamination and on 
culture media containing cycloheximide, such as Mycosel or Mycobiotic agar. 
Cycloheximide inhibits the growth of several anemophilous fungi that can contaminate 
cultures from clinical specimens obtained from non-sterile sites; however, this drug does not 
inhibit the mycelial form of S. schenckii, which grows well on this culture medium (Molinaro 
et al., 2010). 
Traditional identification of S. Schenckii is based on the macro and micromorphologies of the 
mycelial and yeast forms (Figure 8). These analyses, however, do not differentiate the newly 
described species in the S. schenckii complex (Marimon et al., 2007). To differentiate the 
species within this complex, other tests such as carbohydrate assimilation (especially 
sucrose and raffinose), growth rates at 30ºC and 37ºC and the production of dematiaceous 
conidia are necessary. Moreover, molecular methods, which will be discussed below, are 
also important for the differentiation of these new species of Sporothrix. 
Although S. schenckii can grow around body temperature, this is not the optimal 
temperature for this fungus growth. Therefore, to enhance the chance of fungal isolation, 
cultures must be incubated at 25 to 30ºC after removing the fungus from stress condition 
and allowing it to grow, even if the patient fungal burden is low. After five to ten days of 
incubation at 25ºC, filamentous hyaline colonies often start to develop. Only a few strains 
require extended incubation for growth. These colonies, after some time, may develop a 
dark colour, which is usually located in the centre or sectors of the colony (Kwon-Chung & 
Bennett, 1992). If there is no growth of S. schenckii after four weeks of incubation, cultures 
can be considered negative. 
To identify a fungal isolate as S. schenckii, one needs to determinate if it can undergo in vitro 
dimorphism. Thus, it is necessary to make subcultures of the fungus at 35 to 37ºC on 
enriched media such as brain heart infusion (BHI) agar, blood or chocolate agar, for five to 
seven days. Colonies with a creamy texture and with a yellow to tan colour will grow. 
Microscopically, they are composed of round to oval hyaline yeast-like cells that often have 
cigar-shaped narrow base buds (Larone, 2002; McGinnis, 1980). 
Because environmental fungi of the genus Sporothrix can also form yeast-like cells when 
grown on the appropriate medium at temperatures around 35ºC, a micromorphologic study 
of the filamentous form of the isolated fungus is necessary to correctly identify S. schenckii 
because environmental Sporothrix strains are not able to produce the virulence-related 
dematiaceous conidia of S. schenckii (Dixon et al., 1991). Slide culture preparations using 
potato dextrose agar (PDA) or corn meal agar incubated at 30ºC are ideal to study S. 
schenckii conidiogenesis (Marimon et al., 2007). For this test, S. schenckii strains present 
hyaline hyphae usually less than 3 µm in diameter with regular septation and branching 
produced in strands. Hyaline conidia are produced in a flower-like arrangement at the tip of 
the sympodial conidiophores that arises at right angles from the sides of the hyphae. 
Dematiaceous conidia are produced mainly along the hyphae on extremely short denticles 
(Dixon et al., 1991; Kwon-Chung & Bennett, 1992; Larone, 2002). 
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Fig. 8. S. schenckii identification: (A) Mycelial colony on Potato Dextrose Agar (PDA) after 21 
days of incubation at 25ºC. (B) Slide culture of the mycelial form on PDA, incubated at 30ºC 
for 15 days and stained with lactophenol cotton blue. The continuous arrow indicates 
hyaline conidia on a sympodial conidiophore. The dashed arrow indicates dematiaceous 
conidia on a short denticle arising from the hypha. Magnification 400X. (C) Several white, 
smooth yeast colonies on a Brain Heart Infusion (BHI) agar plate after 10 days of incubation 
at 36ºC. (D) Lactophenol cotton blue stain of oval yeast-like cells with cigar-shaped buds 
after growth on BHI agar. Magnification 400X. 
2.3 New diagnostic approaches 
Positive cultures provide the strongest evidence for sporotrichosis, but culture diagnosis has 
significant limitations. In particular, in some manifestations of the disease, such as S. 
schenckii-induced arthritis, the collection of material for culture is difficult (Morris-Jones, 
2002.). Also, sporotrichosis may be mistaken for other infections, such as tuberculosis, 
leishmaniasis, paracoccidioidomycosis, gummatous syphilis, and chromoblastomycosis 
(Rippon, 1988; Sharma et al., 2005). Non-culture methods have been developed to improve 
the rate and speed of diagnosis. These tests include antibody detection as well as newer 
molecular techniques that have been developed to improve the diagnosis and identification 
of Sporothrix spp. in clinical specimens, as well for taxonomic purposes. The results from the 
described tests can provide a presumptive diagnosis of sporotrichosis and require clinical 
correlation for the correct evaluation and determination of the final diagnosis. 
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2.3.1 Serology 
Several methodologies have been described for the immunological diagnosis of 
sporotrichosis based on antibody detection in sera from infected patients. Precipitation and 
agglutination techniques were first used (Albornoz et al, 1984; Blumer et al., 1973; Casserone 
et al., 1983; Karlin & Nielsen, 1970). Double immunodiffusion for sporotrichosis usually 
does not cross-react with sera from patients with chromoblastomycosis or leishmaniasis, 
which are infectious diseases with similar clinical manifestations. Immunoelectrophoresis 
has also been used, and in all positive cases, an anodic arc, called an S arc, is observed 
(Albornoz et al., 1984). Both methodologies that use an antigenic complex from fungal 
culture filtrate are highly sensitive. Tube and latex agglutination both have high sensitivity 
and specificity and have been used for sporotrichosis serodiagnosis since the 1970s 
(Blummer et al., 1973; Casserone, et al., 1983; Karlin & Nielsen, 1970). However, these tests 
lack sensitivity in cases of cutaneous sporotrichosis (Albornoz et.al., 1984; Rippon, 1988) and 
do not permit the determination of the immunoglobulin isotype involved. 
Immunoenzymatic assays are increasingly used for the serodiagnosis of this mycosis. The 
first immunoblot assay used for serodiagnosis of sporotrichosis dates back to 1989, when 
exoantigen preparations from a S. schenckii yeast form presented 100% sensitivity and 95% 
specificity for the detection of antibodies (Scott & Muchmore, 1989). Later, another 
immunoassay (ELISA) was developed, using the concanavalin A binding peptide-
rhamnomanan from the S. schenckii yeast cell wall, and antibodies were detected in 35 serum 
samples from patients with culture proven sporotrichosis, resulting in 100% sensitivity. 
However, the specificity was lower than previous tests because the sera from patients with 
cutaneous leishmaniasis cross-reacted (Loureiro Y Penha & Lopes Bezerra, 2000). The same 
group reported an ELISA test using the same antigenic preparation against sera from 92 
patients with different clinical forms of sporotrichosis in Rio de Janeiro and reported 90% 
sensitivity, 80% specificity, and a global efficiency of 86% (Bernardes-Engemann, et al. 2005). 
Other studies showed that the use of different strains during the preparation of the antigen 
might result in different sensitivity and specificity, despite the purification of the antigen 
involved in this methodology. This difference is due to the O-glycan residues linked to the 
molecules (Bernardes-Engemann, et al. 2009). 
The development of an enzyme immunoassay using exoantigens produced by the mycelia 
phase of a S. schenckii strain isolated in the zoonotic sporotrichosis endemic area of Rio de 
Janeiro was also reported (Almeida-Paes et al., 2007a). This antigen was described by Mendoza 
and collaborators (2002) and showed no cross-reactivity with the antigen and serum samples 
from patients with coccidioidomycosis, histoplasmosis and paracoccidioidomycosis (Mendoza 
et al., 2002). The same antigen was used previously in immunodiffusion and 
immunoelectrophoresis techniques without cross-reactivity with sera from patients with 
leishmaniasis or chromoblastomycosis (Albornoz et.al., 1984). This test had a sensitivity of 97% 
and specificity of 89% when performed on 90 sera from patients with different clinical forms of 
sporotrichosis, 72 sera from patients with other infectious diseases and 76 healthy controls 
(Almeida-Paes et al., 2007a). The overall efficiency of this test for diagnosis and follow-up of 
human sporotrichosis is increased when IgG, IgM, and IgA isotypes are also measured 
providing the most accurate results (Almeida-Paes et al., 2007b). 
When the immunoassays probed with different antigenic preparations are compared, the 
crude exoantigens (Almeida-Paes et al., 2007a) gave values of sensitivity and specificity a 
little higher than those using the concanavalin A binding fraction of the S. schenckii yeast cell 
wall (Bernardes-Engemann, et al. 2005). A similar observation was found when using this 
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purified antigen and crude exoantigens for the serodiagnosis of feline sporotrichosis. 
Purified antigens showed 90% sensitivity and 96% specificity, whereas crude exoantigens 
presented 96% sensitivity and 98% specificity (Fernandes et al., 2011). 
2.3.2 Molecular or DNA-based 
The Sporothrix genus is traditionally identified by phenotypic characteristics, such as macro- 
and micromorphology and sugar assimilation, but Sporothrix spp. colonies grow slowly, and 
differentiation from other fungi that have similar colony or microscopic morphology is 
challenging. To confirm the diagnosis, conversion to the yeast phase should be performed, 
which takes at least 2 to 3 weeks. Methods to identify fungal isolates, such as species-specific 
DNA, can decrease this time-consuming step while maintaining or improving the 
specificity, accuracy and sensitivity. 
Until now, few molecular methods have been applied to the diagnosis of sporotrichosis to 
detect S. schenckii DNA from clinical specimens, and to identify Sporothrix spp. in culture. 
Diagnosis using the Polymerase Chain Reaction (PCR) is based on the amplification of 
fungal gene sequences and is a powerful tool for identifying mycoses. One of the pioneering 
DNA-based methodologies used for the diagnosis of fungal infections was reported by 
Sandhu and collaborators who developed 21 specific nucleic acid probes targeting the large 
subunit rRNA gene from several fungi, including S. schenckii. The results show a high level 
of specificity (Sandhu et al., 1995). 
In past years, several molecular taxonomic studies using different methodologies, such as 
restriction fragment length polymorphism (RFLP) from different gene targets, random 
amplified polymorphic DNA (RAPD), DNA sequencing of internal transcriber spacer (ITS) 
regions of the ribosomal RNA (rRNA), PCR targeting the DNA topoisomerase II gene, 
amplified fragment length polymorphism (AFLP), and M13 PCR fingerprinting have 
demonstrated that Sporothrix schenckii isolates have different genetic characteristics, which 
suggests that they do not belong to the same species (Ishizaki et al., 2000; de Beer et al., 2003; 
Gutierrez-Galhardo et al., 2008; Kanbe et al., 2005; Mesa–Arango et al., 2002; Neyra et al., 
2005; Reis et al., 2009; Watanabe et al., 2004; Zhang et al., 2006). In addition, Marimon and 
collaborators (2007) supported these findings by suggesting that, according to a combination 
of phenotypic and genetic features, S. schenckii should not be considered a single taxon that 
causes sporotrichosis in human and animals but should instead be considered a species 
complex that is comprised of at least four species: S. brasiliensis, S. globosa, S. luriei, and S. 
schenckii (Marimon et al., 2006, 2007, 2008). S. globosa is distributed worldwide (Madrid et al., 
2009; Oliveira et al., 2010), whereas S. mexicana is restricted to Mexico and S. brasiliensis to 
Brazil. Also, S. brasiliensis, S. globosa and S. luriei are related as etiological agents of 
sporotrichosis (Marimon et al., 2007, 2008). Additionally, other phylogenetic analysis based 
on the rDNA and the α-tubulin regions from S. albicans, S. pallida and S. nivea revealed a 
significant similarity. Therefore, it has been proposed that all the three species were called S. 
pallida when they were first described (de Meyer et al., 2008). An identification key for the 
Sporothrix complex has now been proposed (Marimon et al., 2007) that includes analysis of 
conidial morphology, auxonogram analysis using raffinose and sucrose, genotyping via 
PCR amplification, and sequencing of the calmodulin gene. Based on this last analysis, 
Romeo and collaborators (2011), who were studying the molecular phylogeny and 
epidemiology of a S. schenckii species complex isolated in Italy, demonstrated that 26 
environmental strains co-clustered with S. albicans, and two clinical isolates grouped with S. 
schenckii stricto sensu (Romeo et al., 2011). 
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PCR diagnosis based on the amplification of the fungal gene sequences is a powerful tool for 
identifying invasive mycoses. The first description of PCR for the diagnosis of sporotrichosis 
was reported by Kano and colleagues (2001). Specific oligonucleotide primers based on the 
chitin synthase 1 gene were designed, and with this primer pair, PCR was able to detect a 
10 pg genomic DNA fragment of S. schenckii. A nested PCR assay for the detection of S. 
schenckii was evaluated in clinical samples using the 18S rRNA gene sequence as the target. 
However, nested PCR could detect S. schenckii DNA in tissue samples from infected animals 
or from clinical specimens from patients with sporotrichosis confirmed by culture or 
histochemical staining. The test showed high sensitivity and specificity, indicating that the 
assay could provide rapid diagnosis with sufficient accuracy to be clinically useful for 
patients with sporotrichosis (Hu et al., 2003). More recently, the same assay was used to 
detect S. schenckii DNA from 38 strains (including all 24 mitochondrial DNA (mtDNA) 
types) collected from different areas of the world, in the tissues of eight mice infected with 
the ATCC10268 strain of the fungus, and in skin biopsies of nine patients with 
sporotrichosis. In addition, the same procedures were used with two strains of Ceratocystis 
minor and isolates of 10 species of other pathogenic fungi. The authors demonstrated that 
nested PCR could identify S. schenckii from all of the mtDNA types and in isolates recovered 
from different areas of the world, corroborating the data obtained by Hu and collaborators 
(2003) that the nested PCR assay is highly sensitive and specific and is a rapid method for 
diagnosis of sporotrichosis under contamination free conditions (Xu et al., 2010). 
3. Conclusions 
Sporotrichosis is a chronic infection caused by the dimorphic fungus now named the S. 
schenckii species complex. Lymphocutaneous infection is the most common presentation. The 
diagnosis of sporotrichosis is classically attained by correlation of clinical, epidemiological and 
laboratorial data. Considerable advances have been made in non-culture-based diagnosis of 
sporotrichosis with the development of a scarcity of methods for the detection of antibodies, 
antigens, and nucleic acids. The methods described for the diagnosis of sporotrichosis each 
have their strengths and weaknesses and require critical analysis by microbiologists and 
clinicians. However, not all tests described are universally available, which complicates the 
capacity to diagnose and treat individuals with sporotrichosis. Also, the immunological status 
of the patient and manifestation of the disease influences the efficacy of the diagnostic test. 
Continuing efforts to improve or develop diagnostic tests will facilitate our diagnostic 
aptitude. However, such assays will require validation in populations from diverse regions of 
the world prior to general applications in routine diagnosis.  
Results obtained from a panel of serological diagnostic test play an important role in the 
diagnosis of sporotrichosis. Nevertheless, nucleotide probes, specific for the Sporothrix species 
complex, and DNA amplification procedures, such as PCR, allow more rapid and precise 
diagnosis, which can lead to earlier treatment. However, the gold standard in diagnosis 
continues to be culture and the correlation of molecular data and phenotypic characteristics. 
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